Wednesday, February 12, 2020

F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Everyone by APOORVA MANDAVILLI


By APOORVA MANDAVILLI

Citing a lack of evidence, the agency will require Gilead to conduct additional trials in individuals ‘who have receptive vaginal sex.’

Published: October 3, 2019 at 08:00PM

from NYT Health https://ift.tt/31OwHFd
via IFTTT



from WordPress https://ift.tt/39t8xna
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)